UCB USA

Official U.S. page for UCB Biopharma. Patients are at the heart of everything we do. Learn more at www.ucb-usa.com.

UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology. We are unwavering in our purpose: delivering moments that matter for people impacted by severe diseases, now and into the future. People are at the heart of everything we do, inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to be the patient-preferred biopharma leader by delivering medicines and solutions that improve lives while creating value for society.

12/23/2025

Timely and proactive care can make a meaningful difference for people living with epilepsy. We recently worked with Practical Neurology to share the Meitzler family’s experience and highlight perspectives on why early recognition, clear communication, and individualized action plans matter in acute seizure response.

Read the full article here: https://bit.ly/4peEWEH.

12/22/2025

No two journeys look alike when it comes to generalized Myasthenia gravis (gMG), which is why it’s often referred to as “snowflake disease”. ❄️ Their daily experiences and needs can vary widely, making community collaboration essential.

Across the field, we’re inspired by seeing HCPs, advocates, and industry partners rallying around a shared purpose: helping people impacted by gMG live their best lives.

We’re committed to supporting that mission by connecting all of these voices, sharing data, and contributing solutions that can create meaningful progress for all impacted with gMG. Learn about our commitment and work at https://bit.ly/4qklXt7.

12/19/2025

Every study, all the data – it tells a story. And biostatistics helps us understand it. 📈

Nate Bennett, UCB’s Head of Late Development Statistics, shares how biostatistics help turn clinical data into insights that shape safer, smarter treatments for patients everywhere.

Learn more at https://bit.ly/454Nzu8.

12/17/2025

reinforced a critical truth in epileptic care: meaningful scientific progress is driven by collaboration - and bringing together industry partners creates the exchange of insights needed to advance care when every second matters.

We remain committed to working alongside the community to support innovation, accelerate research, and help turn science into solutions for people living with epilepsy and DEEs.

Learn more at https://bit.ly/441E5PM.

12/12/2025

Real progress takes an ecosystem – healthcare practitioners, researchers, advocacy groups and patient communities all bringing their expertise to the same table, according to Guy Eakin, chief scientific and medical officer at the National Psoriasis Foundation.

Strengthening collaboration across the field, from supporting earlier diagnosis to deepening cross-disciplinary connections between rheumatology and dermatology is how we unite perspectives and create solutions that elevate care today and shape better outcomes for tomorrow.

Learn more at https://bit.ly/4pidAym.

12/10/2025

This year’s AES reinforced one truth: the future of epilepsy and DEE care demands bold strategic moves. And UCB is stepping into that future with focus, speed, and commitment 💙💜

Learn more at https://bit.ly/441E5PM.

12/09/2025

For those with chronic inflammatory skin conditions like HS, walking in a bathing suit can feel particularly daunting. So, our HS Warriors took to the runway to show that there is nothing more empowering than being supported to bare your true self, scars and all. We are honored to stand beside them, helping to bring HS into the spotlight.

Learn more here https://bit.ly/4jzzGIO.

12/03/2025

📍 Join us at Dec. 5 - 9 in Atlanta to learn how we’re building on our more than 30-year legacy of partnership and innovation in epilepsy 💜

From debuting Under the Lights, a feature film about living with epilepsy, to sharing 21 new abstracts and clinical data with the community, we’re looking forward to an event full of collaboration and invaluable insight.

Visit booth 205 to connect on the urgent realities of epilepsy and DEE care, our goals to advance medicines beyond seizure control to disease modification, and so much more.

When this community comes together, we make an impact on the families living with epilepsy and rare syndromes.

Learn more at https://bit.ly/441E5PM.

12/02/2025

We’re partnering with Citizen Health to advance data and technology in ways that improve care for people living with epilepsy and rare diseases. By working together, we can make research faster, more patient-centered, and ultimately help close gaps in understanding and treatment, bringing us closer to better outcomes for the communities we serve. Learn more about the partnership here: https://bit.ly/4phJ2wC

12/01/2025

Recognizing rheumatic conditions early can reshape a patient’s future - and catching symptoms sooner helps people stay active, independent, and connected to the parts of life that matter most.

We’re working with clinicians across the rheum and derm communities to strengthen the pathways that lead to earlier diagnosis, from expanding awareness of early warning signs to supporting smarter, more coordinated care systems. When we close gaps in recognition, we open doors to improved long-term outcomes.

Learn more at https://bit.ly/4pidAym.

11/30/2025

At the HS Connect - Hidradenitis Suppurativa Connect event in Times Square, HS warriors shared more than words, they shared truths about the impact of community.

Perseverance, community, and self-acceptance all come from a support system that has helped us partner to build awareness and improve care for this often-overlooked and misunderstood condition.

Learn more at https://bit.ly/4jzzGIO.

11/26/2025

For over 30 years, we’ve been serving the epilepsy community, working hand in hand with advocacy groups like Dravet Syndrome Foundation, caregivers, and patients to drive meaningful change. 💜

Bringing these voices to the table is fundamental to our work to address the urgent realities of living with epilepsy and rare syndromes.

Watch the full conversation with Mary Anne Meskis, CEO of the Dravet Syndrome Foundation here: https://bit.ly/48hUYsg

On our latest Raring to Listen podcast episode to hear how collaboration continues to inspire innovation and impact via https://www.viprarecare.com/.

Address

Atlanta, GA
30080

Telephone

+17709707500

Website

https://www.ucb-usa.com/Contact/Contact-Us

Alerts

Be the first to know and let us send you an email when UCB USA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to UCB USA:

Shortcuts

Want your practice to be the top-listed Clinic in Atlanta?